Grayburn, P A <br/><br/>
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.  [electronic resource] 

 -  Journal of the American College of Cardiology  Jul 1998 
 - 230-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/s0735-1097(98)00219-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Contrast Media<br/>Echocardiography<br/>Emulsions<br/>Endocardium--diagnostic imaging<br/>Female<br/>Fluorocarbons<br/>Heart Diseases--diagnostic imaging<br/>Heart Ventricles--diagnostic imaging<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Sensitivity and Specificity<br/>Single-Blind Method